Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Invested Capital (2016 - 2025)

Pediatrix Medical (MD) has disclosed Invested Capital for 17 consecutive years, with $25.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital fell 96.81% to $25.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.0 million, a 96.81% decrease, with the full-year FY2025 number at $25.0 million, down 96.81% from a year prior.
  • Invested Capital was $25.0 million for Q4 2025 at Pediatrix Medical, down from $1.1 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.9 billion in Q4 2021 to a low of $25.0 million in Q4 2025.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2025 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: skyrocketed 148.59% in 2021, then crashed 96.81% in 2025.
  • Pediatrix Medical's Invested Capital stood at $1.9 billion in 2021, then decreased by 18.95% to $1.5 billion in 2022, then crashed by 43.49% to $864.0 million in 2023, then dropped by 9.3% to $783.6 million in 2024, then plummeted by 96.81% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Invested Capital are $25.0 million (Q4 2025), $1.1 billion (Q3 2025), and $1.0 billion (Q2 2025).